The equipment and inspection instruments of the production line are all advanced pharmaceutical production and inspection equipment in China at present, which have the characteristics of high automation, stable operation and high production efficiency, and provide the basic guarantee for the company to produce high-quality products. Huangshan Shengji Pharmaceutical Co., Ltd. is one of the pharmaceutical preparation manufacturers with the most advanced technology and equipment, the most perfect inspection methods and the largest production scale in Anhui Province. Based on the strategic starting point of high standards, the company's goal is to reach the leading position in the industry in terms of personnel composition and facilities construction. At present, the capital investment is mainly divided into three parts, and the capital investment for factory merger and acquisition is 85 million (including tax and initial inspection fee); The initial start-up cost of infrastructure, fire protection, environmental assessment and power supply is about 4 million yuan (invested); Considering the gradual expansion of the market in the later period, the company has also fully supplemented the capacity design of the whole plant, and plans to invest about100,000 yuan to carry out facility renovation (new flat plate, aluminum-plastic and injection molding linkage lines).
The company strives to put into full production in mid-April. The early stage is mainly evidence collection (drug production license and GMP certification). At present, the renewal of drug production license has been completed, and GMP certification plan will be completed before the end of March. In the later period, on the basis of stabilizing the domestic trade market of existing varieties, the company mainly focuses on international trade. At present, the market distribution is mainly in Africa, South America and Southeast Asia, and the export methods are OEM and self-export. The total trade volume is expected to reach 300 million yuan in two years and exceed 500 million yuan in five years. The company also has long-term strategic considerations in the research and development of new products. At present, it has formed effective strategic cooperation with some foreign-related R&D institutions, and plans to invest 1 billion yuan (60 million yuan has been invested) in the research and development of new products. In the later period, Huangshan Shengji Pharmaceutical Co., Ltd. will surely become the most competitive comprehensive pharmaceutical production enterprise integrating domestic trade and foreign trade.